Trial Profile
To Compare the relative outcomes of Dabigatran and Rivaroxaban versus Warfarin in black and white patients with Atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- 02 Jan 2017 New trial record
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association